+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Alpha interferon alpha ifn vs alpha ifn plus ursodeoxycholic acid udca in chronic hepatitis c ch c a controlled randomized trial



Alpha interferon alpha ifn vs alpha ifn plus ursodeoxycholic acid udca in chronic hepatitis c ch c a controlled randomized trial



Journal of Hepatology 16(Suppl. 1): S48




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 029968685

Download citation: RISBibTeXText


Related references

Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up. American Journal of Gastroenterology 90(2): 263-269, 1995

A randomized controlled trial of amantadine plus interferon alpha-2a vs interferon-alpha-2a in naive patients with chronic hepatitis C randomized based on early response to interferon alpha-2a alone. Hepatology 36(4 Part 2): 589A, 2002

Efficacy of combination therapy of interferon-alpha with ursodeoxycholic acid in chronic hepatitis C: a randomized controlled clinical trial. Journal of Gastroenterology 32(1): 56-62, 1997

A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C. Journal of Viral Hepatitis 12(3): 292-299, 2005

Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferon. Scandinavian Journal of Gastroenterology 35(6): 642-649, 2000

A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy. Journal of Hepatology 34(1): 128-133, 2001

Recombinant alpha 2a interferon r ifn lymphoblastoid alpha interferon 1 ifn or no treatment for non a non b chronic active hepatitis cah a prospective randomized controlled trial. Hepatology 10(4): 637, 1989

Human leucocyte interferon-alpha in chronic hepatitis C resistant to recombinant or lymphoblastoid interferon-alpha: a randomized controlled trial. Journal of Viral Hepatitis 4(3): 209-214, 1997

Randomized controlled trial of polyadenyl followed by alpha interferon versus alpha interferon alone in patients with chronic hepatitis B. Hepatology 26(4 Part 2): 425A, 1997

Therapy of non a non b c chronic hepatitis with recombinant alpha 2a interferon r ifn or lymphoblastoid alpha interferon 1 ifn a randomized controlled clinical trial final report. Journal of Interferon Research 11(Suppl. 1): S247, 1991

Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C. Journal of Viral Hepatitis 8(4): 276-283, 2001

A randomized, double-blind, placebo-controlled trial of interferon-alpha and amantadine versus interferon-alpha alone in the treatment of patients with chronic hepatitis C. Digestive Diseases and Sciences 47(7): 1655-1656, 2002

Double-blind, placebo-controlled trial of interferon alpha-2b plus ribavirin versus interferon alpha-2b for retreatment of patients with chronic hepatitis C who failed previous treatment with interferon alpha. Hepatology 28(4 Part 2): 703A, 1998

Can ursodeoxycholic acid improve effect of alpha-interferon in chronic C hepatitis? Long term results of a randomized trial. Gastroenterology 104(4 Suppl. ): A879, 1993

Randomized, controlled trial with interferon-alpha combined with ribavirin with and without amantadinsulfat in primary IFN-alpha non-responders with chronic hepatitis C. Gastroenterology 120(5 Suppl. 1): A 381, 2001